Obesity has grown to be a full-scale epidemic, and GLP-1s are hailed by some as the miracle cure. What’s your organization’s strategy for addressing increasing consumer demand for weight loss drugs. Will you or won’t you cover the cost of these drugs for your employees and plan members?
GLP-1s and GLP-1/GIPs for weight loss are growing cost drivers for employer-sponsored benefit plans. And the trend is just getting started. Now is the time to make coverage decisions. Download our Employer Impact Report and view our webcast series to chart a clear, informed course forward.
